Skip to main content
OpenTrials
Completed

NCT Number: NCT02356042

Effects of Geriatric Inclusive Art Activity in Nursing Home Residents (GIA)

The study aimed to compare the changes in health and functional status between nursing home residents practicing GIA activity and a control group of residents, and to examine the changes in residents' abilities to participate in GIA activity.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Fondation Cémavie

Nantes, 44300, France

About this study

Geriatric inclusive art (GIA) activity is a derived form of art therapy using painting to make older adults aware of their abilities through an improvement of emotional well-being (1). GIA protected against in-hospital mortality in demented older inpatients and has also been associated with shorter length of hospital stay in geriatric inpatients. These GIA-related positive effects suggest that GIA activity may improve health and functional status in the elderly. To date, effects of GIA on health and functional status in nursing home residents have not been examined.

Based on the previous positive effects reported in older inpatients practicing GIA activity, the investigators hypothesized that GIA activity could improve health and/or functional status of nursing homes residents.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being a resident in the nursing home "la Grande Providence" (Nantes - Loire Atlantique, France)
  • Ability to answer questions
  • Being affiliated to the French health insurance

Exclusion criteria

  • Inability to understand and speak French
  • Opposition to the use of information collected for research purposes

Treatment and study plan

Geriatric inclusive art (GIA) activity

Other

The frequency of GIA sessions in this study was from 1 to 2 per month. The time of a session was around 1 hour 30 minutes. Participants of intervention group benefited GIA activity during a 6-month follow-up period.

Primary outcomes

  1. Change in health and functional status measured by a standardized questionnaire

    Time frame: This outcome is assessed at baseline and at 6 months

    Change in health and functional status was measured by a standardized questionnaire

Secondary outcomes

  1. Change in the number of drugs daily taken assessed by a standardized questionnaire

    Time frame: This outcome is assessed at baseline and at 6 months

    The number of drugs daily taken was assessed by a standardized questionnaire

  2. History of falls in the past 6 months assessed by a standardized questionnaire

    Time frame: This outcome is assessed at baseline and at 6 months

    History of falls was assessed by a standardized questionnaire

  3. Have an unscheduled medical consultation assessed by a standardized questionnaire

    Time frame: This outcome is assessed at baseline and at 6 months

    Unscheduled medical consultation was assessed by a standardized questionnaire

  4. Being hospitalized unscheduled manner assessed by a standardized questionnaire

    Time frame: This outcome is assessed at baseline and at 6 months

    Unscheduled hospitalization was assessed by a standardized questionnaire

Sponsors and collaborators

Lead sponsor

University Hospital, Angers

Other Gov

Collaborators

  • Cémavie

Registry information

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Feb 5, 2015
Registry last updated
Feb 5, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.